Cost-Effectiveness of Biologics as First-Line Treatment of Rheumatoid Arthritis: Case Closed?

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)668-669
JournalAnnals of Internal Medicine
Volume151
Issue number9
DOIs
Publication statusPublished - 2009

Cite this